| - GRCh37:
- Chr17:42455879
- GRCh38:
- Chr17:44378511
| ITGA2B | | Glanzmann thrombasthenia | Pathogenic (Aug 15, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42462702-42462703
- GRCh38:
- Chr17:44385334-44385335
| ITGA2B | | Glanzmann thrombasthenia | Pathogenic (Sep 7, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45384889-45384905
- GRCh38:
- Chr17:47307523-47307539
| EFCAB13-DT, ITGB3 | | Glanzmann thrombasthenia | Likely pathogenic (Aug 15, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42457502-42457506
- GRCh38:
- Chr17:44380134-44380138
| ITGA2B | | Glanzmann thrombasthenia | Uncertain significance (Sep 7, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45367068
- GRCh38:
- Chr17:47289702
| ITGB3 | M321L | Glanzmann thrombasthenia | Uncertain significance (Sep 7, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42461301
- GRCh38:
- Chr17:44383933
| ITGA2B | F320S | Glanzmann thrombasthenia | Likely pathogenic (Aug 15, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42457480
- GRCh38:
- Chr17:44380112
| ITGA2B | Q548* | Glanzmann thrombasthenia | Pathogenic (Jun 1, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42462954
- GRCh38:
- Chr17:44385586
| ITGA2B | N180fs | Glanzmann thrombasthenia | Pathogenic (Jun 1, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42463201
- GRCh38:
- Chr17:44385833
| ITGA2B, LOC130060983 | D133E | Glanzmann thrombasthenia | Pathogenic (Jun 1, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45385004
- GRCh38:
- Chr17:47307638
| EFCAB13-DT, ITGB3 | | Glanzmann thrombasthenia | Pathogenic (Jun 1, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42463476
- GRCh38:
- Chr17:44386108
| ITGA2B | P71R | Glanzmann thrombasthenia | Likely pathogenic (Jun 1, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45363657
- GRCh38:
- Chr17:47286291
| ITGB3, LOC130061043 | Y216H | Glanzmann thrombasthenia | Likely pathogenic (May 16, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45380099
- GRCh38:
- Chr17:47302733
| ITGB3 | K676T | Glanzmann thrombasthenia | Uncertain significance (May 16, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45361920
- GRCh38:
- Chr17:47284554
| ITGB3 | Q158L | Glanzmann thrombasthenia | Uncertain significance (May 16, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42462661
- GRCh38:
- Chr17:44385293
| ITGA2B | V206D | Glanzmann thrombasthenia | Uncertain significance (May 16, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42457765-42457774
- GRCh38:
- Chr17:44380397-44380406
| ITGA2B | Q508fs | Glanzmann thrombasthenia | Pathogenic (May 16, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42457978
- GRCh38:
- Chr17:44380610
| ITGA2B | A477P | Glanzmann thrombasthenia | Likely pathogenic (May 16, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42453354
- GRCh38:
- Chr17:44375986
| ITGA2B | | Glanzmann thrombasthenia | Pathogenic (May 16, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42456035
- GRCh38:
- Chr17:44378667
| ITGA2B | P641L | Glanzmann thrombasthenia | Uncertain significance (May 16, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42453323-42453324
- GRCh38:
- Chr17:44375955-44375956
| ITGA2B | G827fs | Glanzmann thrombasthenia | Likely pathogenic (May 16, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45362046
- GRCh38:
- Chr17:47284680
| ITGB3 | N201fs | Glanzmann thrombasthenia | Pathogenic (Jan 17, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45369900-45369902
- GRCh38:
- Chr17:47292534-47292536
| ITGB3 | S553del | Glanzmann thrombasthenia | Uncertain significance (Apr 6, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45351860
- GRCh38:
- Chr17:47274494
| ITGB3 | C52F | Glanzmann thrombasthenia | Uncertain significance (Apr 6, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45361985
- GRCh38:
- Chr17:47284619
| ITGB3 | G180R | Glanzmann thrombasthenia | Uncertain significance (Apr 6, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45331229
- GRCh38:
- Chr17:47253863
| ITGB3, LOC130061041 | M1T | Glanzmann thrombasthenia | Uncertain significance (Apr 6, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45364542-45364556
- GRCh38:
- Chr17:47287176-47287190
| ITGB3 | | Glanzmann thrombasthenia | Likely pathogenic (Apr 6, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42462973
- GRCh38:
- Chr17:44385605
| ITGA2B | Y174H | Glanzmann thrombasthenia | Likely pathogenic (Apr 6, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42452037
- GRCh38:
- Chr17:44374669
| ITGA2B | G978V | Glanzmann thrombasthenia | Uncertain significance (Apr 6, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42451788
- GRCh38:
- Chr17:44374420
| ITGA2B | W998* | Glanzmann thrombasthenia | Pathogenic (Apr 7, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45377920
- GRCh38:
- Chr17:47300554
| ITGB3 | E664* | Glanzmann thrombasthenia | Pathogenic (Jan 17, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45361832
- GRCh38:
- Chr17:47284466
| ITGB3 | Q129K | Glanzmann thrombasthenia | Uncertain significance (Mar 21, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45364468-45364469
- GRCh38:
- Chr17:47287102-47287103
| ITGB3, LOC130061045 | L271fs | Glanzmann thrombasthenia | Pathogenic (Mar 21, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45361934
- GRCh38:
- Chr17:47284568
| ITGB3 | K163Q | Glanzmann thrombasthenia | Uncertain significance (Mar 21, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42456008
- GRCh38:
- Chr17:44378640
| ITGA2B | | Glanzmann thrombasthenia | Likely pathogenic (Mar 21, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42453485-42453486
- GRCh38:
- Chr17:44376117-44376118
| ITGA2B | D805fs | Glanzmann thrombasthenia | Pathogenic (Jan 17, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42457661
- GRCh38:
- Chr17:44380293
| ITGA2B | I518N | Glanzmann thrombasthenia | Likely pathogenic (Mar 21, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42454380
- GRCh38:
- Chr17:44377012
| ITGA2B | R755Q | Glanzmann thrombasthenia | Uncertain significance (Mar 21, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45364450
- GRCh38:
- Chr17:47287084
| ITGB3 | W264* | Glanzmann thrombasthenia | Pathogenic (Feb 2, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42453709
- GRCh38:
- Chr17:44376341
| ITGA2B | P772R | Glanzmann thrombasthenia | Uncertain significance (Jan 17, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42463023
- GRCh38:
- Chr17:44385655
| ITGA2B | P157H | Glanzmann thrombasthenia | Pathogenic (Feb 2, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45369859-45369860
- GRCh38:
- Chr17:47292493-47292494
| ITGB3 | F539fs | Glanzmann thrombasthenia | Pathogenic (Feb 2, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42466667
- GRCh38:
- Chr17:44389299
| ITGA2B | D59fs | Glanzmann thrombasthenia | Pathogenic (Feb 23, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45376801
- GRCh38:
- Chr17:47299435
| ITGB3 | K606N | Glanzmann thrombasthenia | Uncertain significance (Feb 2, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45369720
- GRCh38:
- Chr17:47292354
| ITGB3 | W492* | Glanzmann thrombasthenia | Pathogenic (Jan 17, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42452029
- GRCh38:
- Chr17:44374661
| ITGA2B | Q981* | Glanzmann thrombasthenia | Pathogenic (Jan 17, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:45363666
- GRCh38:
- Chr17:47286300
| ITGB3, LOC130061043 | V219M | Glanzmann thrombasthenia | Likely pathogenic (Jan 17, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42463377
- GRCh38:
- Chr17:44386009
| ITGA2B | | Glanzmann thrombasthenia | Pathogenic (Jan 17, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42457656
- GRCh38:
- Chr17:44380288
| ITGA2B | M520L | Glanzmann thrombasthenia | Uncertain significance (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42453240
- GRCh38:
- Chr17:44375872
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Mar 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42460875
- GRCh38:
- Chr17:44383507
| ITGA2B | R399Q | not provided, Glanzmann thrombasthenia | Uncertain significance (Dec 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:42455791
- GRCh38:
- Chr17:44378423
| ITGA2B | A678V | Glanzmann thrombasthenia | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42462296
- GRCh38:
- Chr17:44384928
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42460961
- GRCh38:
- Chr17:44383593
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42461949
- GRCh38:
- Chr17:44384581
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Aug 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42458342
- GRCh38:
- Chr17:44380974
| ITGA2B | R433H | Glanzmann thrombasthenia | Uncertain significance (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42453436
- GRCh38:
- Chr17:44376068
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42453040
- GRCh38:
- Chr17:44375672
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42452440
- GRCh38:
- Chr17:44375072
| ITGA2B | L923V | Glanzmann thrombasthenia | Uncertain significance (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42463506
- GRCh38:
- Chr17:44386138
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Sep 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42461681
- GRCh38:
- Chr17:44384313
| ITGA2B | A297T | Glanzmann thrombasthenia | Uncertain significance (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42449796
- GRCh38:
- Chr17:44372428
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (May 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:45361920
- GRCh38:
- Chr17:47284554
| ITGB3 | Q158R | Glanzmann thrombasthenia | Uncertain significance (Jun 1, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:42462679
- GRCh38:
- Chr17:44385311
| ITGA2B | A200V | Glanzmann thrombasthenia | Uncertain significance (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42453026
- GRCh38:
- Chr17:44375658
| ITGA2B | R887Q | Glanzmann thrombasthenia, Inborn genetic diseases | Uncertain significance (Jun 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:42449769
- GRCh38:
- Chr17:44372401
| ITGA2B | R1028Q | Glanzmann thrombasthenia | Uncertain significance (Jul 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42453449
- GRCh38:
- Chr17:44376081
| ITGA2B | | Glanzmann thrombasthenia | Uncertain significance (Aug 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42457474
- GRCh38:
- Chr17:44380106
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Sep 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42457393
- GRCh38:
- Chr17:44380025
| ITGA2B | H577N | Glanzmann thrombasthenia | Uncertain significance (Sep 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42457371
- GRCh38:
- Chr17:44380003
| ITGA2B | R584Q | Glanzmann thrombasthenia | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42449804
- GRCh38:
- Chr17:44372436
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42453234
- GRCh38:
- Chr17:44375866
| ITGA2B | Q856H | Glanzmann thrombasthenia | Uncertain significance (Jun 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42463440
- GRCh38:
- Chr17:44386072
| ITGA2B | G83D | Inborn genetic diseases, Glanzmann thrombasthenia | Uncertain significance (Dec 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:42453322
- GRCh38:
- Chr17:44375954
| ITGA2B | G827V | Glanzmann thrombasthenia | Uncertain significance (Feb 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42462385
- GRCh38:
- Chr17:44385017
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42461254
- GRCh38:
- Chr17:44383886
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42463489
- GRCh38:
- Chr17:44386121
| ITGA2B | V67M | Glanzmann thrombasthenia | Uncertain significance (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42452435
- GRCh38:
- Chr17:44375067
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42453765
- GRCh38:
- Chr17:44376397
| ITGA2B | | Glanzmann thrombasthenia | Uncertain significance (Mar 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42455060
- GRCh38:
- Chr17:44377692
| ITGA2B | | Glanzmann thrombasthenia | Uncertain significance (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42456086
- GRCh38:
- Chr17:44378718
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Jul 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42452961
- GRCh38:
- Chr17:44375593
| ITGA2B | V909L | Glanzmann thrombasthenia | Uncertain significance (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42455805
- GRCh38:
- Chr17:44378437
| ITGA2B | E673D | Inborn genetic diseases, Glanzmann thrombasthenia | Uncertain significance (Oct 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:42456013
- GRCh38:
- Chr17:44378645
| ITGA2B | | Glanzmann thrombasthenia | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42458256
- GRCh38:
- Chr17:44380888
| ITGA2B | G462R | Glanzmann thrombasthenia | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42456009
- GRCh38:
- Chr17:44378641
| ITGA2B | | Glanzmann thrombasthenia | Likely pathogenic (May 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42461457
- GRCh38:
- Chr17:44384089
| ITGA2B | E314G | Glanzmann thrombasthenia | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42452499
- GRCh38:
- Chr17:44375131
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Aug 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42453227
- GRCh38:
- Chr17:44375859
| ITGA2B | P859S | Glanzmann thrombasthenia | Uncertain significance (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42452466
- GRCh38:
- Chr17:44375098
| ITGA2B | A914E | Glanzmann thrombasthenia | Uncertain significance (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42455808
- GRCh38:
- Chr17:44378440
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Aug 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42453659
- GRCh38:
- Chr17:44376291
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Sep 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42458369
- GRCh38:
- Chr17:44381001
| ITGA2B | L424R | Glanzmann thrombasthenia | Uncertain significance (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42461526
- GRCh38:
- Chr17:44384158
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42457985
- GRCh38:
- Chr17:44380617
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42453703
- GRCh38:
- Chr17:44376335
| ITGA2B | R774Q | Glanzmann thrombasthenia | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42452009
- GRCh38:
- Chr17:44374641
| ITGA2B | | not specified, Glanzmann thrombasthenia | Benign/Likely benign (Sep 6, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:42461247
- GRCh38:
- Chr17:44383879
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42461282
- GRCh38:
- Chr17:44383914
| ITGA2B | | Glanzmann thrombasthenia | Likely benign (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42452355-42452356
- GRCh38:
- Chr17:44374987-44374988
| ITGA2B | | Glanzmann thrombasthenia | Uncertain significance (Feb 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:42455747
- GRCh38:
- Chr17:44378379
| ITGA2B | A693T | Glanzmann thrombasthenia | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |